Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Willem J. A. WitloxAntoinette D. I. van AsseltSabine E. Grimm Review Article Open access 09 December 2019 Pages: 317 - 324
Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? Donna RowenOliver Rivero-AriasJulie Ratcliffe Review Article 06 January 2020 Pages: 325 - 340
Cost–Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review Wilfried GuetsHareth Al-JanabiLionel Perrier Systematic Review 19 December 2019 Pages: 341 - 356
Preference-Based Health-Related Quality of Life Outcomes Associated with Preterm Birth: A Systematic Review and Meta-analysis Stavros PetrouNatnaree KrabuanratKamran Khan Original Research Article 09 December 2019 Pages: 357 - 373
Estimating Age- and Sex-Specific Utility Values from the CHU9D Associated with Child and Adolescent BMI z-Score Anagha KilledarThomas LungAlison Hayes Original Research Article 09 December 2019 Pages: 375 - 384
A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity Tim S. GrantDarren BurnsDawn Lee Original Research Article 18 December 2019 Pages: 385 - 395
Determinants of Orphan Drug Prices in Germany Franziska WormCharalabos-Markos Dintsios Original Research Article 06 January 2020 Pages: 397 - 411
A French Value Set for the EQ-5D-5L Luiz Flavio AndradeKristina LudwigGĂ©rard de Pouvourville Original Research Article Open access 08 January 2020 Pages: 413 - 425